Audrey also has extensive experience litigating and advising clients in the areas of antitrust (Sherman Act, Robinson-Patman Act, Cartwright Act) and unfair competition (Lanham Act, Unfair Competition Law, Unfair Practices Act) in both federal and state courts. She has handled cases involving monopolization, price discrimination, tying, price-fixing, below-cost pricing, secret rebates, and locality price discrimination.
Audrey’s clients have included firms that produce chemicals, medical devices, health and nutraceutical products, software, insurance products, and continuing education products.
Audrey advises clients on all issues of Intellectual Property law, including ownership, infringement, invalidity, and patentability. She has also written and obtained the US and foreign patents for chemical compositions, biologically active compounds, methods of detecting disease at the cellular and molecular levels, screening methods for cancer cells, medical devices, biotechnology, computer software, business methods, and mechanical devices.
Before joining Weintraub Tobin in 1990, Audrey practiced for four years in Los Angeles, focusing on litigation involving business and entertainment. In 1989, in a high-profile paternity case in Los Angeles, Audrey obtained the first court order, in any California criminal or civil case, admitting evidence of DNA “fingerprinting.”
Audrey’s undergraduate and graduate degrees focused on cell and developmental biology and included extensive coursework in biochemistry and genetics. During and after graduate school, Audrey worked in the area of recombinant DNA technology.